drug

quaratusugene ozeplasmid

1 story · latest Nov 5, 2026

Timeline

Genprex poster links TUSC2 gene therapy to cellular aging-resilience pathways

Nov 5Clinical readoutGenprex, Inc.quaratusugene ozeplasmid